DIPG: 13-year-old boy reported as the first patient cured after a clinical trial
A 13-year-old diagnosed with diffuse intrinsic pontine glioma (DIPG) took part in the BIOMEDE clinical trial and is reported to be tumor-free after treatment with everolimus; several other trial participants have been long responders.
